Moreover, the use of PCSK9 inhibitors prior to myocardial infarction has been shown to suppress PCSK9 expression, decelerate the process of autophagy, and mitigate myocardial ischemia–reperfusion injury [10]. This evidence concerns the gene PCSK9 and myocardial ischemia.